STAND. COM. REP. NO. 1564
Honolulu, Hawaii
RE: S.R. No. 89
S.D. 1
Honorable Colleen Hanabusa
President of the Senate
Twenty-Fifth State Legislature
Regular Session of 2009
State of Hawaii
Madam:
Your Committee on Health, to which was referred S.R. No. 89 entitled:
"SENATE RESOLUTION REQUESTING THAT THE CENTERS FOR DISEASE CONTROL AND PREVENTION ESTABLISH A CHRONIC OBSTRUCTIVE PULMONARY DISEASE MODULE,"
begs leave to report as follows:
The purpose of this measure is to encourage the creation of a chronic obstructive pulmonary disease module within the Centers for Disease Control and Prevention that will enable information on the potentially debilitating disease to be centralized and coordinated, leading to better sharing of key information and more research and funding for better and effective treatments.
Your Committee received testimony in support of this measure from the Hawaii Chronic Obstructive Pulmonary Disease Coalition.
Written testimony presented to the Committee may be reviewed on the Legislature's website.
Your Committee finds that appropriate funding for the establishment of a national chronic obstructive pulmonary disease program will enable information on the potentially debilitating disease to be centralized and coordinated, leading to better sharing of key information and more research and funding for better and effective treatments.
Your Committee has amended this measure by:
(1) Changing the title to request the establishment of a Chronic Obstructive Pulmonary Disease program instead of a module, and other conforming amendments; and
(2) Making technical, nonsubstantive changes for the purposes of consistency, clarity, and style.
As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee concurs with the intent and purpose of S.R. No. 89, as amended herein, and recommends its adoption in the form attached hereto as S.R. No. 89, S.D. 1.
Respectfully submitted on behalf of the members of the Committee on Health,
|
|
____________________________ DAVID Y. IGE, Chair |
|
|
|